Lv1
50 积分 2025-02-08 加入
Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors for the Treatment of Hyperkalaemia in Children with Chronic Kidney Disease and Heart Failure receiving Renin-Angiotensin-Aldosterone System Inhibitors: A Systematic Review
2个月前
已关闭
Tricuspid annular plane systolic excursion and mitral annular plane systolic excursion cardiac reference values in 1300 healthy children: Single‐center results
2个月前
已完结
Mechanistic Insights of Empagliflozin in Nondiabetic Patients With HFrEF
3个月前
已完结
Obesity-Related Heart Failure With a Preserved Ejection Fraction: The Mechanistic Rationale for Combining Inhibitors of Aldosterone, Neprilysin, and Sodium-Glucose Cotransporter-2
3个月前
已完结
Effects of SGLT2 Inhibitors on Ion Homeostasis and Oxidative Stress associated Mechanisms in Heart Failure
3个月前
已完结
Risk of Heart Failure in Patients With Nonalcoholic Fatty Liver Disease
3个月前
已完结
Progress in the treatment of vascular complications in type 2 diabetes by finerenone in combination with RAS inhibitors/SGLT-2i
3个月前
已完结
SGLT2 inhibitors - a breakthrough in treatment of heart failure and their multipotential beneficial role in cardiology, diabetology, nephrology and neurology
5个月前
已完结
Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of 99,592 patients
5个月前
已完结
Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy
5个月前
已完结
皖公网安备34019202002308
